CisplatinAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsPlatinumDrug Resistance, NeoplasmDrug Administration ScheduleEtoposideLung NeoplasmsOvarian NeoplasmsDeoxycytidineCombined Modality TherapyVinblastineDNA AdductsFluorouracilPaclitaxelCell Line, TumorHead and Neck NeoplasmsCarboplatinIfosfamideTreatment OutcomeVomitingCarcinoma, Squamous CellDrug Screening Assays, AntitumorCarcinoma, Non-Small-Cell LungSurvival AnalysisDoxorubicinDrug SynergismTaxoidsInfusions, IntravenousApoptosisLeukopeniaDose-Response Relationship, DrugDisease-Free SurvivalTumor Cells, CulturedTesticular NeoplasmsNauseaMitomycinSurvival RateCamptothecinNeoplasm StagingVindesineAdenocarcinomaCell SurvivalOxonic AcidDNA DamageCarcinoma, Small CellNeutropeniaBleomycinTegafurStomach NeoplasmsNeoplasms, Germ Cell and EmbryonalAntineoplastic Agents, PhytogenicDNA RepairGerminomaDrug EvaluationNeoplasm Recurrence, LocalDrug ResistanceEsophageal NeoplasmsMesotheliomaChemotherapy, AdjuvantAntiemeticsNeoplasmsMaximum Tolerated DoseEpirubicinPleural NeoplasmsUrologic NeoplasmsThrombocytopeniaOndansetronMice, NudeAmifostineCarcinomaAntimetabolites, AntineoplasticTumor Suppressor Protein p53GuanineCyclophosphamidePlatinum CompoundsRadiation-Sensitizing AgentsInduction ChemotherapyNeoadjuvant TherapyHematologic DiseasesUterine Cervical NeoplasmsOsteosarcomaRemission InductionThiosulfatesDose Fractionation